News Center

2019 Pharmaceutical Industry Review Welcome to the 2020 of Power Supremacy

The earth has completed another revolution around the sun, and the human beings in the eight eastern regions have ushered in a new decade. The years have gone round and round, and the trajectory has returned to the origin. What is the origin of China's pharmaceutical industry? Can we still go back? Do we need to go back? At present, it seems that under the changing pattern of the industry, we no longer need to look back. At the beginning of 2019, the industry predicted that 2019 will be the big year for the landing of China's pharmaceutical industry policy. Under the background of the continuous promotion of policies, various enterprises in the pharmaceutical industry will show different development momentum. Some enterprises grasp the development trend of the industry and gradually transfer their R & D energy to innovative drug research

05-09

2020 Pharmaceutical Industry's First Pure Online Conference

By the speed way health full participation in the organization of the day fine speed smooth listing press conference, this is the pharmaceutical industry in 2020 to "pure online live mode" of the new product listing conference, for the pharmaceutical industry to create a successful precedent, but also for the healthy and orderly resumption of production to play a positive role in encouraging. One-stop solution to the pain points of the brand conference, highlighting the new value of fast-track health marketing activities from offline to online, but does not mean that all links are simply copied. According to the characteristics of the online marketing environment, the Fast Track Health team aggregates vertical and horizontal industrial chain resources in the pharmaceutical field, uses new media resources to build a new marketing scenario for the brand, maximizes the fit between the online communication path and the brand side, gives emotional attributes to the sunny and fast flow, and presents the core and essence of listed new drugs and enterprise brands in a multi-dimensional and three-dimensional manner. In terms of content presentation, the press conference combines policies, closely follows the situation, and integrates the characteristics of the medical industry and new drugs. With the help of online live connection, the time of top experts in the medical field is fully and reasonably used to enhance the interactivity and authority of the content. Through the interpretation of experts in the medical industry, academic experts, business representatives, and the media speak together to make professional and multi-dimensional content more "popular" and "popular"; in terms of communication channels, in addition to the people's health platform of the people's network as the main live broadcast window, the people's network official website, the home page of the people's health channel, the information flow of the people's health APP and the people's good doctor APP also participate in the simultaneous live broadcast, with the sound volume superimposed and spread, striving to make good products fully "dialogue" with the outside world, helping brands to plant grass deeply to target customers, and realize the double the growth of brand communication and sales. This event was unanimously recognized by all parties, and the brand gave Suotu Health a high evaluation. "Zhengda Tianqing's new product launch conference is the first time to use pure online live broadcast for dissemination. It is also the first time that we have cooperated with the People's Health Platform of People's Daily Online. The credibility of our press conference has been greatly improved. This is a form of good interaction between us and the public. At the same time, this cooperation is a very useful attempt by us and the Suotu Health Team, the innovation, flexibility and efficient execution of the Fast Track Health team coincides with Zhengda Tianqing, and finally it is possible to work together to provide a perfect press conference for the public during the epidemic control period." The market is changing, opportunities are fleeting, when experience remains the same and things change, experience becomes a stumbling block. The Suotu Health team has always stressed internally that in an era of great changes, only by resuming trading in time and challenging itself at all times can we really avoid "defeating the opponent but losing to the times" at the root ".

04-26

How to promote the resumption of production in the pharmaceutical industry.

Drugs are an important material basis and condition guarantee for epidemic prevention and control, and are used in the first line of medical treatment to save people and reduce the stock of patients. The material security team has always taken medical security and drug security as the top priority, strengthened the production monitoring of key drugs, comprehensively promoted the resumption of production in the pharmaceutical industry, strengthened the coordination of the production and supply of raw materials, urged enterprises to expand production and transformation, and made every effort to ensure the production and supply of key drugs. There are mainly three aspects of work: first, to carry out the production monitoring of prevention and control drugs. The first time to establish a national key medical materials security scheduling platform, drugs and other key medical materials production resumption of work to track and monitor the situation.

04-22

What benefits will the Belt and Road bring to China's medical and health industries?

At the Belt and Road Forum, China announced that it will continue to strengthen cooperation with countries along the "Belt and Road" to jointly build a "healthy Silk Road". A high-level seminar on "Belt and Road Initiative" and "healthy Silk Road" will be held in Beijing, and cooperation mechanisms such as the "Belt and Road Initiative" Public Health Alliance and the "Belt and Road Initiative" Hospital Clinical Junior College Alliance will be launched to jointly build a "healthy community with a shared future". The Belt and Road Initiative will bring new opportunities to China's health care and health industry, and will work with countries along the route to promote the prevention and control of infectious diseases, such as AIDS, malaria, dengue fever, plague, bird flu, influenza and tuberculosis.

04-17

2019 China Bio & Chemical Pharmaceutical Technology Service Expo

From September 9th to 10th, 2019, the "2019 China Biological & Chemical Drug Technology Service Expo" co-sponsored by Pharmaceutical Finance Circle and Baiao Valley was grandly opened in the beautiful Dushu Lake in Suzhou. More than 2000 innovative drug pioneers, excellent pharmaceutical research, commissioned processing and clinical service enterprises in chemical pharmacy and biology, and elites in the pharmaceutical industry gathered in Suzhou to participate in the Expo to jointly discuss the upgrading of the pharmaceutical industry: from raw materials to preparations, from chemical drugs to biological drugs, from generic drugs to innovative drugs; To find the best technical development, consultation, clinical and

11-18

Publicity: Benzalkonium chloride (RF40)CDE registration number has been publicized

Last week, the registration number of benzalkonium chloride (RF40) of Gedian Renfu Pharmaceutical Accessories Co., Ltd. was publicized on CDE Raw and Auxiliary Package Registration Platform, with the registration number of F20190000408. Benzalkonium chloride (RF40) is also a benzalkonium chloride product launched by our company that can meet the 2020 edition of Chinese Pharmacopoeia standards. Benzalkonium chloride (Benzalkoniumchloride) chemical name is dimethyl benzyl alkyl ammonium chloride, is a quaternary ammonium compound, bacteria, yeast and fungi have a good antibacterial effect. Benzalkonium chloride, as a pharmaceutical excipient, is commonly used in eye and inhalation preparations, and is an effective antibacterial preservative. When the alkyl chain of benzalkonium chloride is different, the bactericidal effect is also different. When the alkyl chain is C12H25, benzalkonium chloride mainly kills fungi, when the alkyl chain is C14H29, benzalkonium chloride mainly kills gram-positive bacteria, and when the alkyl chain is C16H33, benzalkonium chloride benzene mainly kills gram-negative bacteria. The structural formula of benzalkonium chloride Recently, on the official website of the National Pharmacopoeia Commission, the draft of the latest quality standard for benzalkonium chloride 2020 edition pharmacopoeia was publicized. In this quality standard, the alkyl chain ratio of benzalkonium chloride is clearly required, of which n-C12H25 shall not be less than 40%,n-C14H29 shall not be less than 20%, and the total amount of both shall not be less than 70%. Therefore, according to the latest pharmacopoeia standard, Gedianrenfu medicine auxiliary has introduced benzalkonium chloride (RF40) that meets the relevant quality standards. In the draft for soliciting opinions on the quality standard for benzalkonium chloride in the 2020 edition of the Pharmacopoeia, the detection methods for related substances of benzalkonium chloride are also specified, requiring the control of benzyl alcohol, benzaldehyde and benzyl chloride in benzalkonium chloride, of which benzyl chloride is a genotoxic impurity. Through a long period of exploration, Gedian Renfu medicine auxiliary has formed a set of technology to reduce the content of related substances, which can reduce the content of benzyl alcohol and benzaldehyde to less than 0.01%, and the genotoxic impurity benzyl chloride can reach undetected, thus improving the product quality. The following table compares the quality standards of benzalkonium chloride in the 2015 and 2020 pharmacopoeia drafts. Project 2015 version 2020 version of the draft for comments this product is white waxy solid or yellow colloidal body this product is white to yellowish white powder, waxy solid or colorless to light yellow colloidal matter alkyl composition ratio of no n-C12H25 shall not be less than 40%,n-C14H29 shall not be less than 20%, the total amount of the two shall not be less than 70% related substances no benzyl alcohol ≤ 0.5; Benzaldehyde ≤ 0.15%; benzyl chloride ≤ 0.05 pH, clarification and color of solution, water insoluble matter, ammonia compound, moisture, ignition residue and content have not changed. With the approach of the 2020 Pharmacopoeia standard, Gedianrenfu Medicine Co., Ltd. has introduced benzalkonium chloride (RF40) that meets the latest quality requirements. The product has been associated with several preparations. Ge shop people welcome the majority of customers and friends to consult and understand the product. In the next few months, we will also submit research materials on benzyl benzoate (for injection), castor oil (for injection), sesame oil (for injection), peanut oil, sesame oil and other products on the CDE raw package registration platform. It is believed that the high-risk auxiliary materials products of Hubei Gedian Renfu Pharmaceutical Accessories Co., Ltd. will be more and more complete and more and more. Meet the production and R & D needs of domestic pharmaceutical companies and provide more choices for pharmaceutical companies! Link: last week's public number of ethyl paraben and butyl ester.

11-18